Hypertension – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of hypertension includes epidemiological estimates for key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each country, as well as annualized case counts projected to the national population.
Patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report. In addition to forecasting prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy.
Clarivate Epidemiology’s hypertension forecast will answer the following questions:
- Of all people with hypertension, how many in each country under study have been formally diagnosed?
- Of all people diagnosed with hypertension, how many in each country under study are drug-treated?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of hypertension over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts 28 hypertension patient populations, including the following:
- Total prevalent cases of hypertension
- Total prevalent cases of hypertension (per ACC/AHA 2017)
- Total prevalent cases of prehypertension
- Diagnosed prevalent cases of hypertension
- Diagnosed drug-treated prevalent cases of hypertension
- Diagnosed drug-treated-controlled prevalent cases of hypertension
- Diagnosed drug-treated-controlled prevalent cases of hypertension on 1 antihypertensive
- Diagnosed drug-treated-controlled prevalent cases of hypertension on 2 antihypertensives
- Diagnosed drug-treated-controlled prevalent cases of hypertension on 3 antihypertensives
- Diagnosed drug-treated-controlled prevalent cases of hypertension on > =4 antihypertensives
- … and many more (details available on request).
Note: Coverage may vary by country.
Table of contents
- Hypertension - Epidemiology - Mature Markets
- Epidemiology Data
- Methods
- Literature review (studies included in / excluded from the analyses of hypertension)
- Total hypertension prevalent cases
- Total prehypertension prevalent cases
- Diagnosed hypertension prevalent cases
- Diagnosed hypertension drug-treated prevalent cases
- Diagnosed hypertension drug-treated-controlled prevalent cases
- Use of polypharmacy to treat hypertension
- Total hypertension (per ACC/AHA 2017) prevalent cases
- Diagnosed hypertension (per ACC/AHA 2017) prevalent cases
- Diagnosed hypertension (per ACC/AHA 2017) drug-treated prevalent cases
- Use of polypharmacy to treat hypertension (per ACC/AHA 2017)
- Risk / protective factors applied to disease forecast models
- Reference materials
